NATURE’S SUNSHINE PRODUCTS, INC. Revenue, Net (Deprecated 2018-01-31)
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Revenue, Net (Deprecated 2018-01-31) of $87.34 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Income Statement
us-gaap:SalesRevenueNet · last filed 2018-05-10
- NATURE’S SUNSHINE PRODUCTS, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $87.34M, a 5.11% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $88.29M, a 5.16% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $89.30M, a 4.52% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $81.34M, a 8.98% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. revenue, net (deprecated 2018-01-31) for fiscal 2017 was $342.03M, a 0.26% increase from fiscal 2016.
- NATURE’S SUNSHINE PRODUCTS, INC. revenue, net (deprecated 2018-01-31) for fiscal 2016 was $341.16M, a 5.07% increase from fiscal 2015.
- NATURE’S SUNSHINE PRODUCTS, INC. revenue, net (deprecated 2018-01-31) for fiscal 2015 was $324.70M, a 11.37% decline from fiscal 2014.
- NATURE’S SUNSHINE PRODUCTS, INC. revenue, net (deprecated 2018-01-31) for fiscal 2014 was $366.37M, a 0.94% decline from fiscal 2013.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 3 month as first filed | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 6 month as first filed | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 9 month as first filed | Revenue, Net (Deprecated 2018-01-31) 12 month | Revenue, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $87.34M 10-Q · filed 2018-05-10 | $175.63M derived: sum of 2 quarters · filed 2018-05-10 | $264.93M derived: sum of 3 quarters · filed 2018-05-10 | $346.27M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2017-12-31 | $88.29M 10-K · filed 2018-03-16 | $177.59M derived: sum of 2 quarters · filed 2018-03-16 | $258.93M derived: sum of 3 quarters · filed 2018-03-16 | $342.03M 10-K · filed 2018-03-16 | ||||
| 2017-09-30 | $89.30M 10-K · filed 2018-03-16 | $170.65M derived: sum of 2 quarters · filed 2018-03-16 | $253.74M 10-Q · filed 2017-11-09 | $337.69M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2017-06-30 | $81.34M 10-K · filed 2018-03-16 | $164.44M 10-Q · filed 2017-08-09 | $248.39M derived: sum of 3 quarters · filed 2018-05-10 | $333.83M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2017-03-31 | $83.10M 10-Q · filed 2018-05-10 | $167.05M derived: sum of 2 quarters · filed 2018-05-10 | $252.49M derived: sum of 3 quarters · filed 2018-05-10 | $341.86M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | $83.95M 10-K · filed 2018-03-16 | $169.39M derived: sum of 2 quarters · filed 2018-03-16 | $258.76M derived: sum of 3 quarters · filed 2018-03-16 | $341.16M 10-K · filed 2018-03-16 | ||||
| 2016-09-30 | $85.44M 10-K · filed 2018-03-16 | $174.81M derived: sum of 2 quarters · filed 2018-03-16 | $257.21M 10-Q · filed 2017-11-09 | $337.20M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-06-30 | $89.37M 10-K · filed 2018-03-16 | $171.77M 10-Q · filed 2017-08-09 | $251.76M derived: sum of 3 quarters · filed 2018-03-16 | $331.35M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-03-31 | $82.40M 10-K · filed 2018-03-16 | $162.40M derived: sum of 2 quarters · filed 2018-03-16 | $241.98M derived: sum of 3 quarters · filed 2018-03-16 | $323.23M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2015-12-31 | $79.99M 10-K · filed 2017-03-14 | $159.58M derived: sum of 2 quarters · filed 2017-03-14 | $240.83M derived: sum of 3 quarters · filed 2017-03-14 | $324.70M 10-K · filed 2018-03-16 | ||||
| 2015-09-30 | $79.59M 10-K · filed 2017-03-14 | $160.83M derived: sum of 2 quarters · filed 2017-03-14 | $244.71M 10-Q · filed 2016-11-09 | $331.37M derived: sum of 4 quarters · filed 2017-03-14 | ||||
| 2015-06-30 | $81.25M 10-K · filed 2017-03-14 | $165.13M 10-Q · filed 2016-08-09 | $251.79M derived: sum of 3 quarters · filed 2017-03-14 | $345.19M derived: sum of 4 quarters · filed 2017-03-14 | ||||
| 2015-03-31 | $83.88M 10-K · filed 2017-03-14 | $170.54M derived: sum of 2 quarters · filed 2017-03-14 | $263.95M derived: sum of 3 quarters · filed 2017-03-14 | $356.78M derived: sum of 4 quarters · filed 2017-03-14 | ||||
| 2014-12-31 | $86.66M 10-K · filed 2016-03-14 | $180.07M derived: sum of 2 quarters · filed 2016-03-14 | $272.90M derived: sum of 3 quarters · filed 2016-03-14 | $366.37M 10-K · filed 2017-03-14 | ||||
| 2014-09-30 | $93.41M 10-K · filed 2016-03-14 | $94.88M 10-Q · filed 2014-11-06 | $186.24M derived: sum of 2 quarters · filed 2016-03-14 | $279.70M 10-Q · filed 2015-11-06 | $284.95M 10-Q · filed 2014-11-06 | $372.97M derived: sum of 4 quarters · filed 2016-03-14 | ||
| 2014-06-30 | $92.83M 10-K · filed 2016-03-14 | $94.33M 10-Q · filed 2014-08-07 | $186.30M 10-Q · filed 2015-08-10 | $190.08M 10-Q · filed 2014-08-07 | $279.56M derived: sum of 3 quarters · filed 2016-03-14 | $369.97M derived: sum of 4 quarters · filed 2016-03-14 | ||
| 2014-03-31 | $93.47M 10-K · filed 2016-03-14 | $95.75M 10-Q · filed 2014-05-08 | $186.73M derived: sum of 2 quarters · filed 2016-03-14 | $277.14M derived: sum of 3 quarters · filed 2016-03-14 | $368.92M derived: sum of 4 quarters · filed 2016-03-14 | |||
| 2013-12-31 | $93.26M 10-K · filed 2015-03-13 | $95.48M 10-K · filed 2014-03-17 | $183.67M derived: sum of 2 quarters · filed 2015-03-13 | $275.45M derived: sum of 3 quarters · filed 2015-03-13 | $369.83M 10-K · filed 2016-03-14 | $378.10M 10-K · filed 2014-03-17 | ||
| 2013-09-30 | $90.41M 10-K · filed 2015-03-13 | $92.46M 10-Q · filed 2013-11-08 | $182.19M derived: sum of 2 quarters · filed 2015-03-13 | $282.61M 10-Q · filed 2014-11-06 | $366.94M derived: sum of 4 quarters · filed 2015-03-13 | |||
| 2013-06-30 | $91.78M 10-K · filed 2015-03-13 | $93.67M 10-Q · filed 2013-08-09 | $190.15M 10-Q · filed 2014-08-07 | $276.53M derived: sum of 3 quarters · filed 2015-03-13 | $367.77M derived: sum of 4 quarters · filed 2015-03-13 | |||
| 2013-03-31 | $94.38M 10-K · filed 2015-03-13 | $96.48M 10-Q · filed 2013-05-09 | $184.75M derived: sum of 2 quarters · filed 2015-03-13 | $275.98M derived: sum of 3 quarters · filed 2015-03-13 | $368.98M derived: sum of 4 quarters · filed 2015-03-13 | |||
| 2012-12-31 | $90.38M 10-K · filed 2014-03-17 | $181.61M derived: sum of 2 quarters · filed 2014-03-17 | $274.60M derived: sum of 3 quarters · filed 2014-03-17 | $360.83M 10-K · filed 2015-03-13 | $367.47M 10-K · filed 2013-03-07 | |||
| 2012-09-30 | $91.23M 10-K · filed 2014-03-17 | $184.22M derived: sum of 2 quarters · filed 2014-03-17 | $277.09M 10-Q · filed 2013-11-08 | $369.15M derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-06-30 | $92.99M 10-K · filed 2014-03-17 | $185.86M 10-Q · filed 2013-08-09 | $277.92M derived: sum of 3 quarters · filed 2014-03-17 | $369.02M derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-03-31 | $92.87M 10-K · filed 2014-03-17 | $184.92M derived: sum of 2 quarters · filed 2014-03-17 | $276.03M derived: sum of 3 quarters · filed 2014-03-17 | $367.84M derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2011-12-31 | $92.06M 10-K · filed 2013-03-07 | $183.16M derived: sum of 2 quarters · filed 2013-03-07 | $274.97M derived: sum of 3 quarters · filed 2013-03-07 | $367.81M 10-K · filed 2014-03-17 | ||||
| 2011-09-30 | $91.10M 10-K · filed 2013-03-07 | $182.91M derived: sum of 2 quarters · filed 2013-03-07 | $275.76M 10-Q · filed 2012-11-06 | $365.65M derived: sum of 4 quarters · filed 2013-03-07 | ||||
| 2011-06-30 | $91.81M 10-K · filed 2013-03-07 | $184.66M 10-Q · filed 2012-08-03 | $274.54M derived: sum of 3 quarters · filed 2013-03-07 | $360.64M derived: sum of 4 quarters · filed 2013-03-07 | ||||
| 2011-03-31 | $92.84M 10-K · filed 2013-03-07 | $182.73M derived: sum of 2 quarters · filed 2013-03-07 | $268.83M derived: sum of 3 quarters · filed 2013-03-07 | $355.97M derived: sum of 4 quarters · filed 2013-03-07 | ||||
| 2010-12-31 | $89.89M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $175.99M derived: sum of 2 quarters · filed 2013-03-07 | $263.13M derived: sum of 3 quarters · filed 2013-03-07 | $349.92M 10-K · filed 2013-03-07 | ||||
| 2010-09-30 | $86.10M 10-Q · filed 2011-11-08 | $173.24M derived: sum of 2 quarters · filed 2011-11-08 | $260.03M 10-Q · filed 2011-11-08 | |||||
| 2010-06-30 | $87.14M 10-Q · filed 2011-08-05 | $173.93M 10-Q · filed 2011-08-05 | ||||||
| 2009-12-31 | $342.11M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |